{"id":30026,"date":"2022-12-24T18:15:56","date_gmt":"2022-12-24T18:15:56","guid":{"rendered":"https:\/\/www.banglanewsus.com\/english\/?p=30026"},"modified":"2022-12-24T18:15:56","modified_gmt":"2022-12-24T18:15:56","slug":"biontech-starts-human-trial-to-test-malaria-vaccine","status":"publish","type":"post","link":"https:\/\/www.banglanewsus.com\/english\/2022\/12\/24\/biontech-starts-human-trial-to-test-malaria-vaccine\/","title":{"rendered":"BioNTech starts human trial to test malaria vaccine"},"content":{"rendered":"<p>International Desk: BioNTech on Friday initiated an early-stage study to evaluate its experimental malaria vaccine in humans, the German drugmaker said.<\/p>\n<p>The Phase 1 trial is expected to enrol 60 volunteers in the United States with no history of malaria to assess the vaccine candidate at three-dose levels.<\/p>\n<p>Known as BNT165b1, it is the first vaccine candidate from BioNTech&#8217;s malaria project, which will also establish vaccine production in Africa.<\/p>\n<p>The effort is one of several focused on addressing the mosquito-borne disease that kills over 600,000 each year, most of them children in Africa. The complicated structure and lifecycle of the malaria parasite has long stymied efforts to develop vaccines.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>International Desk: BioNTech on Friday initiated an early-stage study to evaluate its experimental malaria vaccine in humans, the German drugmaker said. The Phase 1 trial is expected to enrol 60 volunteers in the United States with no history of malaria to assess the vaccine candidate at three-dose levels. Known as BNT165b1, it is the first vaccine candidate from BioNTech&rsquo;s malaria project, which will also establish vaccine production in Africa. The effort is one of several focused on addressing the mosquito-borne disease that kills over 600,000 each year, most of them<\/p>\n","protected":false},"author":2,"featured_media":30027,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[30,11],"tags":[],"_links":{"self":[{"href":"https:\/\/www.banglanewsus.com\/english\/wp-json\/wp\/v2\/posts\/30026"}],"collection":[{"href":"https:\/\/www.banglanewsus.com\/english\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.banglanewsus.com\/english\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.banglanewsus.com\/english\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.banglanewsus.com\/english\/wp-json\/wp\/v2\/comments?post=30026"}],"version-history":[{"count":1,"href":"https:\/\/www.banglanewsus.com\/english\/wp-json\/wp\/v2\/posts\/30026\/revisions"}],"predecessor-version":[{"id":30028,"href":"https:\/\/www.banglanewsus.com\/english\/wp-json\/wp\/v2\/posts\/30026\/revisions\/30028"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.banglanewsus.com\/english\/wp-json\/wp\/v2\/media\/30027"}],"wp:attachment":[{"href":"https:\/\/www.banglanewsus.com\/english\/wp-json\/wp\/v2\/media?parent=30026"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.banglanewsus.com\/english\/wp-json\/wp\/v2\/categories?post=30026"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.banglanewsus.com\/english\/wp-json\/wp\/v2\/tags?post=30026"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}